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CASE REPORT
Hafnia alvei is a Gram-negative bacillus belonging
to the family Enterobacteriaceae, and it is believed
to be an opportunistic pathogen responsible for
causing invasive disease in debilitated patients.1,2
This bacillus is rarely associated with invasive
disease in pediatric patients, especially in the
young-infant period.1–8
We report the case of a 39-day-old infant with
urinary tract infection combined with sepsis due
to H. alvei infection. We also review the relevant
literature for previously reported cases of extrain-
testinal invasive disease suspected to have been
caused by H. alvei and occurring in pediatric 
patients.
Case Report
A 39-day-old infant presented to the emergency
department at a local hospital for evaluation of 
a fever of approximately 48 hours’ duration. The
infant’s initial physical examination was notable
for a body temperature of 38.6°C and demon-
strated irritability, although there appeared to be
no obvious foci of infection. The contact history
for the infant was traced back for the preceding
several days during which time the patient had had
a diaper change alongside another infant who was
suffering from acute gastroenteritis at that time.
Our patient’s past history revealed that he was
delivered by an uncomplicated vaginal delivery
following a gestation period of 37 weeks, and that
there appeared to have been no history of a pro-
longed rupture of the membrane. The infant’s
birth weight was 3070 g and there appeared to
have been no prenatal, peripartum or postpartum
complications reported for either the patient or
his mother.
At the local hospital, the complete blood cell
count revealed a white blood cell (WBC) count of
14.7 × 103/μL, featuring 40.9% neutrophils, 56.1%
lymphocytes, and 2.0% monocytes. The C-reactive
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protein (CRP) level appeared to be elevated to
16.1 mg/dL. Urine analysis revealed abundant
leukocytes (WBC count >100/high powered field),
and positive leukocyte esterase reaction (3+).
Infant blood and urine (via bladder catheteriza-
tion) samples were cultured, and antibiotic treat-
ment with ampicillin and gentamicin commenced
at the local hospital under the suspicion of a
condition of sepsis. The infant was transferred to
our hospital the following day due to persistent
fever, and the blood culture yielded certain
Gram-negative bacilli. At our hospital, the infant
appeared acutely ill and displayed a rather poor
activity level. Initially, he had a body temperature
of 38.7°C, a respiration rate of 41 breaths/minute,
a blood pressure of 96/68 mmHg, and a heart
rate of 145 beats/minute. The complete blood
cell count revealed a WBC count of 29.5 × 103/μL,
featuring 30.0% neutrophils, 45.0% lympho-
cytes, and 12.0% monocytes. The CRP level was
14.27 mg/dL. A lumbar puncture was performed
and revealed clear cerebrospinal fluid (CSF) with
zero WBC/mL, normal glucose (41 mg/dL) and
protein (41 mg/dL) levels, and no evident organ-
isms upon Gram-staining. Latex agglutination
antigen studies of CSF revealed negative results
for group-B Streptococcus, Haemophilus influenzae
type B, Streptococcus pneumoniae, and Neisseria
meningitides. The CSF culture was negative for any
specific micro-organisms. However, the initial cul-
tures of blood and urine obtained at the referring
hospital all showed that H. alvei grew in a pure
isolate (> 105 colonies) and all featured the same
antibiotic susceptibility. H. alvei was identified by
the computer-assisted Vitek 2 System GN card
(BioMerieux Vitek Inc., Hazelwood, MO, USA) plus
conventional biochemical test for further identi-
fication. Biochemical reactions for which H. alvei
were positive included lysine decarboxylase, orni-
thine decarboxylase, and mannitol fermentation,
whereas it was negative for fermentation of sorbitol,
inositol, sucrose, and melibiose; these negative re-
actions differentiated H. alvei from Enterobacter
aerogenes. For those cultures, antimicrobial suscep-
tibility was performed by the disc-diffusion
method, which revealed that H. alvei was resistant
to ampicillin, cefazolin, piperacillin, chloram-
phenicol, and trimethoprim-sulfamethoxazole,
and was susceptible to amoxicillin/clavulanate,
cefaclor, cefotaxime, ceftriaxone, gentamicin, ami-
kacin, ciprofloxacin, and meropenem. The patient
was treated with a 14-day course of ceftriaxone at
our institution and recovered completely.
In addition, he also underwent a 2,3-dimercap-
tosuccinic acid (DMSA) renal scan and sonography
of the kidneys. The DMSA renal scan demon-
strated no evidence of pyelonephritis, while kidney
sonography revealed bilateral mild hydronephro-
sis. Otherwise, all results from the patient’s im-
munologic evaluation (including serum IgA, IgM,
IgE, IgG, and IgD levels, lymphocyte profile, and
C3, C4, and CH50) lay within the normal ranges.
Furthermore, an HIV enzyme-linked immunosor-
bent assay antibody test was negative.
Discussion
H. alvei is a motile, facultatively anaerobic, Gram-
negative bacillus, formerly referred to as Enterobacter
hafnia.1,9 This organism typically constitutes a
component of the normal human gastrointestinal
flora and is typically found in environmental
habitats such as surface water and certain foods.1
These bacteria are rarely isolated from human
specimens and are thought to be rarely patho-
genic.9 In 1991, Albert et al10 identified this organ-
ism as an enteric pathogen, noting that several
cases of diarrhea caused by H. alvei had previously
been reported in the literature, such cases arising
mainly in children. Subsequent to the findings of
Albert et al, several cases of extraintestinal infec-
tions, including septicemia, endocarditis, menin-
gitis, pneumonia, abscess, and surgical-wound
infection, have been reported.4,5,9–11
H. alvei is a rare but significant etiologic agent
of nosocomial and community-acquired infec-
tions.9 It is primarily isolated from patients fea-
turing underlying illness, apart from cases when
it exists as an enteric pathogen.9,10,12 Some iatro-
genic factors have been associated with H. alvei
bacteremia, including abdominal surgery, the
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presence of central venous catheters, endotracheal
tubes and urethral catheters, and/or previous 
administration of antibiotics.9,11
The pathogenesis of the invasive disease re-
mains somewhat unclear, but the gastrointestinal
tract has been implicated as a frequent source of the
infection.11 To our knowledge, the first reported
case of purulent meningitis ascribable to H. alvei
was in 1978, when it was assumed that the gas-
trointestinal tract was the port of entry for the
bacteria and that meningitis arose secondarily to
bacteremia.7 In our case, the patient did feature a
urinary tract infection and also bacteremia, and
had a contact history with another infant who suf-
fered from acute gastroenteritis at the time of con-
tact. Such a medical scenario may suggest that 
H. alvei was retrograded to the urinary tract from
where it then induced bacteremia.
H. alvei would appear to be an infrequently
reported pathogen among children, and its isola-
tion from a neonate or a young infant is even more
unusual.1,2 This organism is rarely associated with
invasive disease, but it may be a pathogen among
neonates.1,2 In 1988, Ginsberg and Goldsmith2
suggested that attempts should be made to iden-
tify this bacillus (if present), such that additional
information may be elucidated if H. alvei was
isolated from blood or stool samples taken from
neonates. In 2004, the first case of late-onset
neonatal sepsis caused by H. alvei in an infant who
featured no underlying disease was reported.1
Here, we have summarized previously (English)
literature-reported cases of extraintestinal inva-
sive infections in pediatric patients caused by 
H. alvei, including our own case (Table). Of 
the eight literature-reported pediatric cases of 
extraintestinal invasive infections caused by 
H. alvei, six occurred in males, two occurred in
neonates, and one occurred in a young infant. Four
cases cited underlying conditions, including acute
nonlymphocytic leukemia after allogeneic bone
marrow transplantation, preterm infant with
necrotizing enterocolitis, human immunodefi-
ciency virus infection, and liver transplantation.
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Table. Clinical features of pediatric cases featuring extraintestinal invasive infections caused by Hafnia alvei
Patient
Age Gender
Specimen Underlying Antibiotic 
Outcome Reference
no. source disease therapy
1 13 yr F Blood No CAR + GEN,  Recovered Grajwer et al6
stop GEN 
2 1 yr F CSF No GEN add Died Mojtabaee & 
CLI + TET Siadati7
3 6 yr M Blood ANLL after AMI + C + Recovered Yeager et al8
allogeneic BMT TIC × 14 d
4 20 d M Blood, stool Preterm 31 wk MET + GEN Recovered Ginsberg & 
with NEC add TIC, stop Goldsmith2
perforation GEN × 14 d
5 8 yr M Blood HIV infection TMP-SMX Recovered Conte et al5
add CTRX
6 2 yr M Blood, Liver TMP-SMX + AMP + Recovered Barry et al4
abscess transplantation GEN × 11 d
7 8 d M Blood No CTX × 10 d Recovered Casanova-
Roman
et al1
8 39 d M Blood, urine No CTRX × 14 d Recovered Present case
CSF = cerebrospinal fluid; ANLL = acute nonlymphocytic leukemia; BMT = bone marrow transplantation; NEC = necrotizing 
enterocolitis; HIV = human immunodeficiency virus; CAR = carbenicillin; GEN = gentamicin; CLI = clindamycin; TET = tetracycline; 
AMI = amikacin; C = chloramphenicol; TIC = ticarcillin; MET = methicillin; TMP-SMX = trimethoprim-sulfamethoxazole; CTRX = ceftri-
axone; CTX = cefotaxime.
Subsequent to adequate antibiotic treatment,
seven cases exhibited a full recovery. For the 
remaining one case, that of a 1-year-old female 
infant with H. alvei meningitis, the patient
showed only a slight improvement subsequent
to antibiotic treatment and, unfortunately, died of
Pseudomonas aeruginosa sepsis.7 For the seven
cases that recovered, 10–14 days of antimicrobial
therapy proved to be entirely effective for full 
patient recovery.
H. alvei is usually resistant to ampicillin and
first-generation cephalosporins because it features
inducible and constitutive beta-lactamases, and
under certain circumstances, can develop resistance
to second- and third-generation cephalosporins.1
For severe cases, treatment with imipenem or a
third-generation cephalosporin in combination
with an aminoglycoside is recommended by many
clinicians.9,11 In general, piperacillin and gen-
tamicin have been previously shown to be active
against H. alvei.9,11,13 According to our review 
in children, four cases (cases 5, 6, 7, 8; Table) 
underwent antibiotic-susceptibility testing prior
to treatment. Three of them who underwent an-
tibiotic-susceptibility testing for ampicillin were
resistant (75% resistant). Two cases underwent
antibiotic-susceptibility testing for piperacillin and
revealed 100% resistance; four cases underwent
susceptibility testing for gentamicin and the resist-
ance rate was 25%. Apart from the abovementioned
antibiotics, we noted that amikacin, imipenem
and/or meropenem, and third-generation cepha-
losporins were the most effective antimicrobials
for the four cases (zero resistance). In our case,
ceftriaxone was used for 14 days, with a successful
outcome.
Cases of urinary tract infections due to H. alvei
among adults have been reported previously. The
largest case study report, which included 80 iso-
lates of H. alvei recovered from 61 patients, re-
ported that there were 12 such isolates detected
from the urogenital tracts of seven patients.9
Further, Ramos and Damaso11 described three
adult cases of hospital-acquired urinary tract in-
fection, of which two patients had undergone
previous urethral catheterization. This finding
emphasizes the potential role of urethral catheters
in the acquisition of nosocomial urinary tract in-
fections.11 Here, we have reported a rare case of
young-infant sepsis combined with urinary tract
infection caused by H. alvei. This is the first 
literature-reported case of urinary tract infection
combined with sepsis caused by H. alvei in a young
infant who featured no other underlying disease. 
In conclusion, our case reminds diagnosing
physicians that the possibility of an extraintestinal
invasive infection such as bacteremia or urinary
tract infection being caused by H. alvei should 
be taken into account in young infants who fea-
ture no apparent underlying disease. For cases of 
H. alvei infection featuring extraintestinal infection,
effective treatment should be carefully selected
based on the results of preliminary antimicrobial-
susceptibility testing. Cases usually recover un-
eventfully after adequate antibiotic treatment for
10–14 days, except for the case of central nervous
system infection. Although there would appear
to be an absence of any large pediatric case stud-
ies relating to this topic reported in the literature,
increased awareness and evaluation of the sus-
ceptibility pattern of the organism would allow
appropriate antibiotic therapy in the future.
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